# Oligomerization enables the selective targeting of an intrinsically disordered region by a small molecule

**Authors:** Stasė Bielskutė-García, Borja Mateos, Muhammad Awawdy, Carla Garcia-Cabau, Henri Niskanen, Carolina Sánchez-Zarzalejo, Lorenzo Bracaglia, Roberta Pierattelli, Isabella C. Felli, Marta Frigolé-Vivas, Jesús García, Antoni Riera, Denes Hnisz, Xavier Salvatella

PMC · DOI: 10.1126/sciadv.adz7400 · Science Advances · 2026-02-27

## TL;DR

A small molecule can selectively target a disordered protein region by interacting with its structured oligomeric form, changing its behavior and function.

## Contribution

The study reveals that oligomerization enables selective targeting of intrinsically disordered regions by small molecules.

## Key findings

- A small molecule interacts selectively with an oligomeric form of an intrinsically disordered region.
- The interaction alters the conformational ensemble and biophysical properties of phase-separated condensates.
- The molecule attenuates RNA polymerase II recruitment in cells.

## Abstract

Intrinsically disordered regions (IDRs) in proteins are increasingly recognized as attractive targets for therapeutic intervention. A number of small molecules interacting with IDRs have been identified, but the lack of persistent secondary and tertiary structure of these regions has led to the prevailing view that they cannot be targeted selectively. Here, we show that a small molecule targeting an IDR evaluated in a clinical trial interacts selectively with an oligomeric form of its target, which is more structured than the monomer and is stabilized by interactions involving aromatic residues in partially α-helical regions. The interaction reshapes the conformational ensemble of the target, alters the biophysical properties of its phase-separated condensates in vitro, and attenuates RNA polymerase II recruitment in cells. Our findings provide mechanistic insights into how small molecules can selectively recognize IDRs.

The druggability of intrinsically disordered regions.

## Full-text entities

- **Genes:** CFP (complement factor properdin) [NCBI Gene 5199] {aka BFD, PFC, PFD, PROPERDIN}, TFPI (tissue factor pathway inhibitor) [NCBI Gene 7035] {aka EPI, LACI, TFI, TFPI1}
- **Diseases:** AD (OMIM:612348), CSPs (MESH:D019966), prostate cancer (MESH:D011471), sarcoma (MESH:D012509), DIC (MESH:D005119)
- **Chemicals:** TFA (MESH:D014269), Ser (MESH:D012694), oil (MESH:D009821), Arg (MESH:D001120), thiol (MESH:D013438), aspartate (MESH:D001224), AA (MESH:D000596), MgSO4 (MESH:D008278), urea (MESH:D014508), aminobutyric acid (MESH:D000613), disulfide (MESH:D004220), EPI-001 (MESH:C551471), sodium phosphate (MESH:C018279), glycerol (MESH:D005990), 2Tau-5 (-), He (MESH:D006371), DMSO (MESH:D004121), norleucine (MESH:D009646), 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (MESH:C078178), Tween 20 (MESH:D011136), Lys (MESH:D008239), H (MESH:D006859), Tau (MESH:C000609666), Cys (MESH:D003545), maleimide (MESH:C043592), CO2 (MESH:D002245), ACN (MESH:C032159), Ala (MESH:D000409), polyethylene glycol (MESH:D011092), His (MESH:D006639), EDTA (MESH:D004492), TCEP (MESH:C080938), FA (MESH:C030544), Tc (MESH:D013667), polyG (MESH:D011068), NaCl (MESH:D012965), proline (MESH:D011392), 13C (MESH:C000615229), glycine (MESH:D005998), CaCl2 (MESH:D002122), DTT (MESH:D004229), glutamate (MESH:D018698), HCl (MESH:D006851), ascorbic acid (MESH:D001205), PR (MESH:D011374), Iodoacetamide (MESH:D007460), silane (MESH:D012821), imidazole (MESH:C029899), Tyr (MESH:D014443), phenol (MESH:D019800), H2O (MESH:D014867), D2O (MESH:D017666), NaN3 (MESH:D019810)
- **Species:** Escherichia coli BL21(DE3) (strain) [taxon 469008]
- **Mutations:** T435P, W433A, C448, G394A, F437A, W397A, C404Y, G407A, L436P, C129S, E2621X, C404S, Y406S, CtoS, C448S, C3010I, C404, C518, C518S, L26P, H413A, Y393S, H434A, A398P, S395A
- **Cell lines:** pET-50b — Homo sapiens (Human), Minimally invasive lung adenocarcinoma, Cancer cell line (CVCL_WG67), BL21 (DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), U2OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947862/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12947862/full.md

## References

78 references — full list in the complete paper: https://tomesphere.com/paper/PMC12947862/full.md

---
Source: https://tomesphere.com/paper/PMC12947862